Lund, Sweden

Niklas Patrik Sköld

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Acadia Pharmaceuticals Inc.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niklas Patrik Sköld. Retrieved from https://idiyas.com/inventor/niklas-patrik-sköld

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Niklas Patrik Sköld

Introduction

Niklas Patrik Sköld is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating diseases. With a total of 3 patents to his name, Sköld's work is recognized for its potential impact on medical treatments.

Latest Patents

Sköld's latest patents include innovative compounds and methods aimed at addressing various diseases. One of his patents focuses on "Compounds, salts thereof and methods for treatment of diseases," which relates to compounds according to Formula (I) that are useful for treating diseases. Another patent also titled "Compounds, salts thereof and methods for treatment of diseases" expands on this by detailing compounds according to Formulae (I), (II), and (VIII) that are beneficial for treating diseases.

Career Highlights

Niklas Patrik Sköld is currently associated with Acadia Pharmaceuticals Inc., where he continues to advance his research and development efforts. His work at Acadia Pharmaceuticals has positioned him as a key player in the pharmaceutical industry, contributing to innovative solutions for healthcare challenges.

Collaborations

Sköld has collaborated with esteemed colleagues such as Ethan S. Burstein and Roger Olsson. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in the field.

Conclusion

Niklas Patrik Sköld's contributions to the pharmaceutical industry through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…